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Endometriosis is a chronic inflammatory disease under hormonal/non-
hormonal regulation, and microenvironment influences, originating in adult stem 
cells (mainly of bone marrow/endometrial progenitor mesenchymal type), and 
their exosomes, with special migratory and adhesion capacities. The postmenstrual 
repair with regeneration of eutopic and ectopic endometrium has similar genetic 
and epigenetic changes versus disease-free women. The competition between ecto-
pic and eutopic endometrium for a limited supply of stem cells, and the depletion 
of normal stem cells flux to the uterus is considered the novel mechanism through 
which endometriosis interferes with endometrial functions and fertility. The 
gene expression DNA/RNA or microRNA changes/dysregulation of estrogen and 
progesterone receptors represent a possible explanation of progesterone resistance 
or loss of progesterone signalling in ectopic, and eutopic endometrium versus 
normal. The genes’ changes involved in hormonal/non-hormonal pathways control 
of eutopic/ectopic endometrial cells, and of invaded tissues/organs may explain the 
disease persistency, progression and severity. Deficient DNA methylation of ERβ, 
the initial genomic event is followed by pathologic over-expressed ERβ in ectopic 
stromal cells, and it dictates the decline of PR isoforms, PRB being significantly 
lower in ectopic and eutopic endometrium. Altered expression of ERα, ERβ, and 
PRs accompanies the conversion of resident normal endometrial cells to ectopic 
lesions.
Keywords: endometriosis, progesterone resistance, stem cells, steroid receptors, 
genomic, epigenetics
1. Introduction
Endometriosis is a chronic inflammatory disease, estrogen-dependent and 
progesterone-resistant, with a multifactorial etiology, which can appear from 
intrauterine life [1, 2] and can progress and aggravate as a hidden disease in 
adolescence [3], being more common during reproductive years, when it is more 
studied. It is an invasive and metastatic disease, being different from malignancies 
by missing nuclear atypia [4]. Endometriosis is characterized and diagnosed by 
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the presence and growth of endometrial-like glands and stroma outside the uterine 
cavity and musculature, which undergoes cyclic proliferation and breakdown 
similar to the eutopic endometrium, with peculiar symptoms in most cases, and 
non-specific also in others. The genetic predisposition, and the epigenetic changes, 
the systemic, and local environmental factors, and the dysfunctions in endocrine 
and immune systems, which make possible the new cellular connections induced 
by exosomes between original tissues and ectopically attached adult stem cells, 
with bone marrow or endometrial source, are believed to a play significant role in 
the establishment, maintenance, and progression of endometriosis [5, 6] and its 
consequences on women’s fertility and quality of life. The human endometrium is 
an angiogenic tissue, with enormous waves of regenerative capacities through cell 
proliferation, differentiation, and recruitment of inflammatory cells, with episodes 
of apoptosis and events of breakdown and regeneration without scar, but in ectopic 
endometrium progression to deeply infiltrative lesions, the scar is present in the 
form of important fibrosis. The ovarian hormones, estrogens, and progesterone 
through their receptors—genetic and epigenetic regulated—play an important role 
in physiology and pathophysiology of eutopic and ectopic endometrium. Excess 
estradiol and progesterone resistance are documented in eutopic and ectopic 
endometrium of ill women.
2. Origin and qualities of ectopic endometrium
2.1 Hypotheses and theories on the mechanisms of ectopic endometrium 
development in different stages
Endometriosis is a multifactors disease, a disease of hypothesis and theories, 
and many concepts are elaborated in order to elucidate the diagnosis and treat-
ment, to stop the chronic pains and the progression which is like that of a cancer, 
and the possible malignant transformation in 1% cases [7, 8]. There were explored 
multiple hypotheses and theories, being reloaded of some old ones, in the condi-
tions of the modern technological possible pathological assessments of eutopic and 
ectopic endometrium (flow cytometry, immunohistochemistry, genetic analysis), 
in association with evidences from animal models as mice, rats, baboons, and 
marmosets [9].
The most referred hypothesis was based on the retrograde deposits of viable 
endometrial fragments refluxed through the fallopian tubes during the men-
struation into the peritoneal cavity, where they attach and invade the peritoneal 
mesothelium or pelvic organs to establish ectopic growth of endometrial tissue. It 
is known as J. Samson’s theory—or the “transplantation” theory—which is the most 
widely accepted [10].
The retrograde menstrual blood flow is present in nearly 90% of women [11], 
but women who develop endometriosis have larger volumes of retrograde menstrual 
flow than women without disease [12]. The retrograde blood flow is considered to 
be at the origin of ectopic endometrium in early onset endometriosis (EOE), start-
ing around thelarche/menarche or early adolescence, and EOE may have an origin 
different from the adult variant, originating from neonatal uterine bleeding [13].
Besides the transportation of endometrial debris from uterine cavity through 
the fallopian tubes to the peritoneal and organs’ surface, the rare condition of the 
dissemination through regional lymphatic circulation and lymph nodes [14, 15] to 
extrapelvic, distant organs, with no direct connection to the uterus- thorax, brain, 
and its structures, is discussed [16]. Since many years have passed, other factors 
associated with retrograde menstrual blood flow, such as the uterine contractions 
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during menstruation [17, 18] and/or the involvement of peritoneal fluid [19, 20] 
as favorable factors for the transportation and spread of retrograde endometrial 
debris in the peritoneal cavity, are discussed. The retrograde endometrial debris 
are associated to the adhesive, proliferative, and invasive properties of endome-
trial cells, mainly of the stromal/mesenchymal ones [21], and to the chemokines 
(E-cadherin, N-cadherin) elaborated by endometrial cells [22, 23], and in connec-
tion to leukocyte actions [24, 25] and to the adhesion properties of the mesothelium 
are explained the ectopic endometriosis lesions. It is considered that in patients with 
endometriosis it is a real cross talk between endometrial stromal cells and mesothe-
lial cells, which have a common embryological origin, as it will be discussed later. 
The new tissue injury and repair (TIAR) concept is comparable [26, 27]: uterine 
dysperistalsis and hyperperistalsis may induce more trauma, with dislocation of 
more basal endometrium, and a greater number of stemlike cells present in the 
retrograde refluxed menstrual blood.
Other two theories are partially connected to one another and to embryologic 
development. The “coelomic metaplasia” theory—according to the same cell lineage 
origin of the thoracic, abdominal, and pelvic peritoneum, the Müllerian ducts, and 
the ovarian germinal epithelium, all being derived from the coelomic wall epithe-
lium of developing embryo, and through metaplasia they generate endometriosis 
[28]. The second “embryological theory” is very old [29, 30], and it considers the 
embryonic rests, considering that the presence of cells with the Müllerian origin 
within the peritoneal cavity are induced to form endometrial tissue when subjected 
to the appropriate stimuli. von Recklinghausen [29] from Austria was the first who 
described this disease at the level of the uterus (adenomyomas and cystadenomas) 
and the tube, and in his opinion their origins were remnants of the Wolffian 
body. The embryological theory has been recently re-proposed by the scientists 
from the Italian Foundation of Endometriosis (Rome) (Signorile PG, Baldi A) [8] 
and the lympho-vascular metastasis or the iatrogenic direct graft implant or the 
“implantation” theory. Their concept is based on the stem cells as origin of ectopic 
endometrium.
Hypotheses and theories are actually combined, being considered that endome-
triosis is the final stage of the combination of some aberrant biological processes, 
some starting from the intrauterine life, like the “Müllerianosis”: the endometrial 
cells are dislocated outside the uterus during organogenesis, at the moment of 
mesoderm differentiation from the Müllerian ducts [2, 31]. “Müllerianosis” was 
revealed by immunohistochemistry in human female fetuses at different gestational 
ages by the scientists from the Italian Foundation of Endometriosis, from Rome  
[1, 2, 8]. The Italian scientists have discovered ectopic endometrial cells in five dif-
ferent ectopic sites, outside the uterine cavity, being cited the rectovaginal septum, 
the proximity of the Douglas pouch, the mesenchymal tissue close to the posterior 
wall of the uterus, and the rectal tube at the level of muscularis propria and in 
the wall of the uterus. All these areas are common places of endometriosis in adult 
women.
Another theory explains that the retrograde menstrual blood flow is possible 
in women with a genetic predisposition and with an improper innate immune 
answer, which is conditioned by the exposure to some environmental factors 
[5]. Recently, the local microenvironment or the peritoneal involvement in the 
defense against uterine menstrual debris [endometrial cells with plasticity and in 
terminal differentiation state, plus microvesicles (composed of diverse types of 
membranes of plasma and endosomal membrane origin) and exosomes released 
from the endometrial cells] is considered to play a crucial role in the develop-
ment of endometriosis [6]. The human endometrial exosomes and nanopar-
ticles (∼100 nm diameter) released from endometrial cells are mediating the 
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intercellular connection/communication, and they can transfer small RNAs and 
mRNA via the extracellular environment to cells at distant sites [32, 33], especially 
in the stroma as happens in cancer [34], a fact that will be discussed in the next 
subchapters. The peritoneal clearance through apoptosis of the implanted ectopic 
endometrial islands from the uterine debris is under genetic, immune system and 
sexual steroid hormone control. The nature of predisposing individual genetic, 
biochemical, and hormonal factors or inherent defects of the endometrium, 
peritoneal cavity, or immune system of patients with endometriosis is unclear 
[35]. There are controversies if endometriosis is an autoimmune disease due to 
anti-endometrial antibodies, which were detected in the serum of women with 
endometriosis and on the increase/decrease/balance in the activity of T-helper1 
(Th-1)/T-helper 2 (Th-2) cells in women with endometriosis [36], associated with 
anti-inflammatory cytokines as IL-4, IL-6, and IL-10, which primarily regulate 
the intensity and duration of the inflammatory response by suppressing the 
effects of pro-inflammatory cytokines [interleukin-1 (IL-1), tumor necrosis factor 
alpha (TNF-α), interferon gamma (IFN-γ), and granulocyte-macrophage colony-
stimulating factor (GM-CSF), although some have also inflammatory roles [37]. 
The pro-inflammatory cytokines primarily initiate and amplify the inflammatory 
response to endometrial debris by signaling the recruit of additional immune 
cells and pro-inflammatory mediators to the site of endometrial cell adherence. 
IL-6 is most studied, being with prominent inflammatory and anti-inflammatory 
functions, which challenge the understanding of its full role in endometriosis. 
IL-6 is mainly produced by macrophages, and by Th-1 cells and B cells, fibroblasts 
and endothelial cells may produce IL-6 specially in women with endometriosis, 
who have higher levels of this cytokine in ectopic and eutopic endometrium and 
much higher with the severity stage of disease than normal women [38]. All these 
cytokines and chemokines discovered in endometriosis development are similarly 
involved in pelvic inflammatory disease and are under genomic and hormonal 
control through their microRNA receptors, inclusive for progesterone, with well-
known anti-inflammatory actions.
Three different forms of endometriosis are described in the pelvic cavity: 
peritoneal, ovarian, and deeply infiltrating lesions. The development of endome-
trial ectopic island on the parietal peritoneal surface or different organs’ surfaces is 
an end point of many molecular mechanisms necessary for the establishment and 
survival of endometrial implants that may have common origin to the peritoneum. 
The steps described in endometriotic lesion development are analyzed since many 
years. After the shedding of viable endometrial cells during menstruation, the 
retrograde transport of exosomes (vesicles released by the endometrial cells in the 
terminal state of differentiation and with plasticity) and menstrual cells, with their 
attachment to the peritoneum and formation of temporary ectopic lesion, under 
the control of immune system is necessary. The invasion into the mesothelium, 
survival, and proliferation of the ectopic endometrial cells with endometriotic 
lesion formation is the final step [5, 6]. In healthy women, the immune system 
removes the temporary ectopic lesions through apoptosis induction. The released 
exosomes of ectopic endometrial cells could facilitate immune evasion; enhance 
proliferation, invasion, and angiogenesis in the lesion, and subsequently progress 
into a persistent endometriotic lesions. Exosomes could therefore be one important 
factor to enable a temporary endometriotic lesion to establish a sufficient blood 
supply in order to grow and survive at the ectopic site, as they act in an autocrine, 
paracrine, and endocrine manner in intercellular communication. The current 
knowledge suggests different roles of endometrial fragments outside the uter-
ine cavity: the endometrial stromal cells are involved in the attachment to the 
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peritoneum, whereas endometrial glandular epithelial cells primarily play a role in 
the invasion and growth of the lesion. These events are possibly related to a defect 
in the ability of peritoneal natural killer (NK) cells to eliminate the endometrial 
fragments regurgitated with menstrual debris by lysis and by the release of soluble 
non-specific factor(s) which interfere with NK cells from human endometrial 
stromal cells [39], as well as higher levels of IL-6, which suppress them [40]. The 
human endometrial mesenchymal stem cells (HMSCs) have another capacity, that 
of transdifferentiation or metaplasia, which permits them to differentiate in cells 
without any embryological connection, or to complete differentiated cells, with 
the change of phenotype [41], a biologic event supposed to be during the dormant 
phase from fetal life to adolescence [42]in association to some external triggers as 
transient hypoxia, chronic inflammation.
Endometrial cells are able to exploit the promotion of vasculogenesis and angio-
genesis mediated by the inflammatory response that they trigger in cooperation 
with both immune cells and local tissue, usually the peritoneum. In advanced stages 
of illness, the ectopic endometrium islands have an enormous development of blood 
vessels, a high degree of fibrosis, and a degree of neurogenesis. Blood vessel devel-
opment depends on two processes induced by ectopic endometrial islands—vascu-
logenesis and angiogenesis—triggered by the endothelial progenitor cells (EPCs) 
with bone marrow stem cell origin or endometrial progenitor/regenerative/stem cell 
origin. The high levels of angiogenetic factors as vascular endothelial growth factor 
(VEGF) and other angiogenic factors including IL-6, IL-8, and TNF-α mediate the 
process of angiogenesis by activating angiogenic switch of endothelial cells. Lesion 
local production of estradiol maintains the expression of VEGF and promotes 
macrophages to produce VEGF and monocyte chemoattractant protein (MCP)-1. 
Thereby, intercellular communication mediated via exosomes could represent a 
missing link between the different theories on the pathogenesis of endometriosis. 
Exosomes released by eutopic or ectopic endometrium or shedded endometrial 
cells could induce metaplasia of cells at ectopic sites (“coelomic metaplasia” and 
“induction” theories) or aid in tissue remodeling after injury (TIAR concept) 
(Figure 1) [26].
In 2018, a team from Saint Petersburg [43] published a hypothesis on the 
existence of a special endometriosis development program (EMDP) which switches 
on in the progenitor/stem cells (SCs) of the endometrium in SCs descended from 
the Müllerian duct; EMDP suggests that the cells are prone to give rise to endome-
triosis partly through endometrial-mesenchymal transition, their invasivity into the 
peritoneum lining, and differentiation and growth into endometriotic lesions.  
The EMDP was subdivided into three parts: the first one in intrauterine period and 
the last two in the postnatal life. (1) Transition of mesodermal embryonic cells into 
cells of the endometrium within Muller duct rudiments, (2) acquisition of endome-
trial cell abnormalities and cell transition into endometriotic SCs, and (3) invasion 
of the SCs into the peritoneum lining and their differentiation into endometriotic 
lesions (Figure 2).
2.1.1 The new concept of stem cells for the development of endometriosis
Stem cells are undifferentiated cells with the capacity to remain in this stage for 
some generations, after cell proliferations. Maintenance of the stem cell population 
requires cellular self-renewal, i.e., the capacity to generate identical daughter cells. 
Alternatively, stem cells can undergo asymmetric division, producing an identical 
daughter cell and a more differentiated daughter, or symmetric division producing 
two daughter stem cells or two transit-amplifying progenitors. Although neither 
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progenitors nor precursors are called stem cells, it is often practically difficult 
to distinguish adult stem cells from their progenitor/precursor cells. Indeed, for 
instance, a small subset of hematopoietic progenitor cells have been termed hema-
topoietic stem cells (HSCs).
The stem cells have in vivo the capacity to participate to natural phenomenon as 
the repair and regeneration of damaged tissues, as is the endometrium during and 
after menstruation.
Since then, in many populations worldwide, adult stem cells (ASCs)—known 
as somatic stem cells or tissue-specific stem cells, such as the blood [44], intestines 
[45], muscles [46], skin [47], nervous system [48–50], heart, liver [51, 52], dental 
pulp, adipose tissue, synovial membrane, umbilical cord blood, amniotic fluid  
[53, 54], and the endometrium [55–58], are found.
The human endometrium is an extraordinary model for controlled tissue remod-
eling. The endometrial tissue renewal at each menstrual cycle during reproductive 
years (about 7 mm within 1 week in every menstrual cycle, and 500 menstrual 
cycles during a woman’s lifetime) [44], and in postpartum, with conservation of 
Figure 1. 
Molecular and cellular pathways in endometriosis. Adapted from Klemmt et al. [6].
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this capacity even in postmenopausal years during hormone therapy, is actually 
explained by the presence of adult stem cells; there are controversies on these cells 
origin—bone marrow stem cells or endometrial stem cells—epithelial, stromal/ 
mesenchymal, endothelial, niche and side population stem cells [55, 59–61]. There 
are studies on these types of cells in many research laboratories and medical centers 
from Australia, Brazil, the USA, Italy, France, Romania, Spain, and the UK, as 
well as there are controversies if endometrial epithelial cells are derived from the 
bone marrow [62, 63]. Independent of their origin, the endometrial stem cells are 
developing the ectopic island of endometriosis from the intrauterine life in female 
gender [59, 61, 64], and after a dormant period of life, at the menarche they restart 
their aggressive actions, modulated by sexual steroid hormones.
The concept of endometrial origin of stem cell populations was first proposed 
by Prianishnikov VA in 1978 [65] due to the highly regenerative nature of the 
endometrium, and actually the medical communities are waiting to produce novel 
therapies with these progenitor cells in regenerative medicine, even in infertility 
from endometriosis [55, 61, 66].
2.2 Adult bone marrow stem cells as the origin of ectopic endometrium
It was postulated that stem cells (SCs) that originated from bone marrow could 
be attracted in the human endometrium, with generation of endometrial epithelial 
and stromal cells [61, 67], from the fetal life, but their participation in endome-
triosis should be proven [68, 69], and mesenchymal bone marrow SCs (bmSCs) 
in inflammation sites in the peritoneum were found [70]. An Australian team who 
analyzed the endometrial stem cells for 10 years after their first published paper 
[61] considers the stem cells originating in the bone marrow to be fibroblasts with 
Figure 2. 
Neovascularization and ectopic endometrium growth on peritoneal surface. Adopted from Ahn et al. [35]. This 
is an open-access article distributed under the Creative Commons Attribution Noncommercial License, which 
permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is 
properly cited.
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clonogenicity, plastic adherence properties, and multilineage differentiation into 
bone and marrow lineages in cultures, and they renamed these cells as multipotent 
mesenchymal stromal cells maintaining the acronym MSCs, for bmMSCs. These 
cells have comparable properties to stromal endometrial stem subpopulation cells, 
which will be discussed in the next subchapter.
2.3 Endometrial stem/regenerative/progenitor cells as the origin for ectopic 
endometrium: the novel concept on HESCs and their progenitor cell 
capacities
After the preliminary hypothesis and discussion regarding the recovering 
capacities from the basalis of the primate endometrium, as a bifunctional ger-
minal compartment [65, 71, 72], and the discovery of endometrial regenerative/
progenitor/stem cells [55, 56, 73–75], with their presence in the menstrual blood 
[76–78], a new hypothesis/concept which tries to clarify the underlying patho-
physiologic mechanisms of endometriosis, besides the proposed conventional 
theories explaining the three different aspects of endometriosis, was elaborated. 
In the concept of Padykula et al. [72] after the menstrual shedding of endome-
trial functionalis layer, the remaining basal layer was believed to behave as a 
germinal compartment from which various types of endometrial cells proliferate 
and differentiate, suggesting that putative endometrial stem cells reside in the 
basalis. Endometrial stem cells have the characteristics of adult stem cells (ASCs), 
namely, the clonogenicity and high ability to proliferate, differentiate, and induce 
rapid angiogenesis, a fact that may contribute to consider their binary qualities in 
natural functions in the normal endometrium and in endometriosis [5, 79]. Their 
involvement in endometriosis is from intrauterine life [64], with reactivation after 
a dormant period in adolescence years in the form of so-called early-onset endo-
metriosis (Figure 3) [80].
There are described different types of human endometrial stem cells (HESCs): 
epithelial—with confirmed location in the basalis of endometrial epithelium, as 
was postulated [72] stromal/mesenchymal, endothelial, side population—which 
can differentiate into epithelial and stromal endometrial cells [81], a niche for 
human epithelial stem cells, and label-retaining cells (LRCs) [82]. All these stem 
cells can be actually identified with specific markers for immunohistochemistry in 
endometrial biopsy and/or can be isolated from menstrual blood, being available 
some devices, as menstrual cups for collection [83]. After repeated examinations 
of endometrium specimens in all phases of the menstrual cycle, it was concluded 
that endometrial regenerative cells are located in the basalis, the functionalis being 
shed at every menstruation, and the basalis which remains intact is the origin of 
each new cycling endometrium [73]. At 10 years after their first published paper 
on human and mouse endometrial stem cells, isolated from uterine tissue at hyster-
ectomy, Gargett et al. [61]—from Monash University and Monash Medical Centre 
(Australia)—are discussing HESC involvement in uterine pathology (endometrio-
sis, adenomyosis, Asherman syndrome, endometrial cancer). The mesenchymal/
stromal/endometrial stem cells (eMSCs) or fibroblasts are the most studied. When 
compared to mesenchymal bone marrow stem cells, there are some differences 
regarding eMCS abilities to generate a vascularized stroma, with the capacity to 
differentiate into decidualized stroma when transplanted into an animal at the 
single-cell level. The eMCSs produced endometrial stroma and incorporated into 
renal parenchymal blood vessels when xenografted under the kidney capsule of 
immunocompromised NSG mice [84].
Human endometrial mesenchymal stem cells (HMSCs) were identified with 
specific markers used for their enrichment [CD146(+)PDGFRβ(+) (platelet-derived 
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growth factor receptor β) and SUSD2(+) (sushi domain containing-2), and they 
were distinguished from stromal fibroblasts. HMSCs were located perivascular, 
and like the pericyte, they were identified in endometrial basalis and functionalis 
vessels [78]. These Australian researchers presented the similarities and differ-
ences between eMSCs and endometrial stromal fibroblasts and the identity of bone 
marrow-derived cells involved in endometrial function.
It is a novel concept regarding the migratory and invasive abilities of HESCs 
and their progenitor cells, being increasingly recognized their contribution to the 
intense tissue remodeling associated with embryo implantation, trophoblast inva-
sion, endometrial regeneration, and endometriosis/adenomyosis progress [85]. 
Numerous reports indicate that endometriosis and adenomyosis are associated 
with increased basal and stimulated invasiveness of HESCs and their progeni-
tor cells, suggesting a link between a heightened menstrual repair response and 
the formation of ectopic implants. The abilities of migration and invasiveness of 
HESCs are controlled by a complex array of hormones—estradiol and proges-
terone, growth factors, chemokines, and inflammatory mediators—and involve 
signaling through Rho GTPases, phosphatidylinositol-3-kinase, and mitogen-
activated protein kinase pathways, studied in laboratories from Western Europe 
(Germany, The Netherlands, Italy), first in early pregnancy and later in endome-
trial pathology [86, 87].
Figure 3. 
Localization of human endometrial mesenchymal stem cells. (A–C) Immunofluorescence images of human 
endometrium showing perivascular identity of human eMSCs. (A) Co-localization (white arrows) of CD146 
and platelet-derived growth factor receptor beta (PDGF-Rβ) in pericytes of venules and possibly capillaries 
in the functionalis stroma. (B) Perivascular SUSD2 expression (white arrows). (C) ATP-binding cassette, 
subfamily G member 2 (ABCG2) and αSMA co-staining showing perivascular and endothelial identity of SP 
cells. The white dotted lines indicate the junction between the endometrium (en) and myometrium (my) and 
yellow dotted line indicates the luminal surface (lu) of the uterine epithelium. (D) Schematic showing location 
of stem/progenitor cells identified in the human endometrium. Epithelial progenitor cells are postulated 
to be a subpopulation of cells located in the basalis, in the base of the glands, by SSEA-1 marker. Sushi 
domain containing-2+ (SUSD2+) eMSCs are perivascular cells. eMSC co-expressing CD146 and PDGFRβ/
CD140b are most likely pericytes, as they are located adjacent to endothelial cells in vessels (v) in both the 
basalis and the functionalis. SP cells are a heterogeneous population comprising CD31+ endothelial cells 
and CD140b+CD146+ pericytes. Scale bar in (A) = 50 µm. (A) Adopted from Gargett et al. [61]. This is an 
open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License 
(http://creativecommons.org/licenses/by-nc/4.0/), which permits noncommercial reuse, distribution, and 
reproduction in any medium, provided that the original work is properly cited. For commercial reuse, please 
contact journals.permissions@oup.com.
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The clonogenic qualities of epithelial and mainly of stromal/mesenchymal stem 
cells, in association with the migratory and invasive qualities of the last ones from 
the eutopic endometrium of women with endometriosis, may explain the develop-
ment of endometriosis. It can be discussed if stem/progenitor cells which develop 
the implants of endometriosis are abnormal by the increase of their capabilities to 
stabilize and implant in ectopic islands, through the lack of the tumor suppressor 
molecule E-cadherin [22], or if normal stem/progenitor cells are implanting on 
abnormal peritoneum [88].
In other studies, the answers to these issues were to discuss a combination of the 
genetic predisposition or the special immunohistochemical pattern of mesenchymal 
or stromal stem cells from the retrograde menstrual blood flow, with high expression 
of CD9, CD10, and CD29− [89], and/or with DNA/RNA changes, and/or with an 
improper immune response possible at exposure at some environmental factors [5].
2.4 Comparison of eutopic and ectopic endometrium with normal cycling 
endometrium
Normal endometrium is containing large quantities of distinct stromal cells 
with abundant PRs, which influence epithelial cell proliferation and differentiation 
and protect against carcinogenic transformation. In endometriosis, eutopic and 
ectopic tissues do not respond sufficiently to progesterone, being considered to be 
progesterone-resistant, a fact that contributes to proliferation and survival of ecto-
pic endometrium. The ectopic endometrium is similar to eutopic endometrium but 
with some peculiarities. The restoration of eutopic endometrium after each men-
struation is without scar, a fact that is not present in ectopic endometrium, which 
undergoes cyclic proliferation and breakdown similar to the endometrium, but 
with a fibrotic progressive scar. On the other hand, between the two endometrial 
areas are very strong connections, considered to be bidirectional, and a competition 
between ectopic and eutopic endometria for a limited supply of stem cells, with 
different origins, that contribute to restoration/repair of eutopic endometrium after 
menstruation or other pathological conditions, and the depletion of normal stem 
cells flux to the uterus is a novel mechanism by which endometriosis interferes with 
endometrial function and fertility [90].
The phenotype, proliferative, and differentiation in vitro capacities of stromal 
cells from ectopic lesion from peritoneum, ovarian and deeply infiltrating endome-
triosis in comparison to the same structures of normal women, were analyzed using 
the contrast microscopy, immunocytochemistry, and functional bioassays [21]. 
The doubling time of stromal cells from the deeply infiltrating lesions is lower 
than that of endometrial stromal cells, and the levels of prolactin and insulin-like 
growth factor-binding protein-1 (synthesized by the stromal cells) are reduced in 
supernatants from stromal cells derived from the three types of lesions and from the 
endometrium of ill women. The conclusion of the British doctors was that endome-
triotic cell lines and endometrial cells from women with endometriosis are losing 
the capacity of differentiation, which can explain the cells’ capacities for prolifera-
tion and survival in the ectopic environment.
When treating the complications of endometriosis, it is recommended to evalu-
ate not only the effect on the endometriotic lesion itself, but it is also essential to 
consider the effect on normal uterine endometrium in the categories of reproduc-
tive age population, including stem cell recruitment as an essential means of uterine 
repair [90].
The molecular analyses of eutopic and ectopic endometrium versus endome-
trium of disease-free women are bringing us some news for endometrial patholo-
gies—endometriosis and endometrioid endometrial cancer. The activation of AKT 
11
Progesterone Resistance and Adult Stem Cells’ Genomic and Epigenetic Changes in the Puzzle…
DOI: http://dx.doi.org/10.5772/intechopen.84203
pathway in endometriosis is reported in a relatively small number of studies. The 
study of p(Ser473)-AKT in ectopic and eutopic tissue in different stages of the 
menstrual cycle depicted a higher level of the AKT in endometriotic tissues [91], 
mainly from ovarian endometriomas, a fact confirmed by other studies, which have 
revealed in examined endometrioma tissues an association of lower levels of PTEN 
in epithelial cells of both endometrial types [92–94].
3. Progesterone resistance in endometriosis
3.1 Short history of progesterone resistance/pseudocorpus luteum insufficiency
Progesterone resistance (PR) was first described and nominated as pseudocor-
pus luteum insufficiency [95], being considered as a local defect of progesterone 
(P4) action on endometrial stroma. The patient with this disorder was an infertile 
woman with normality regarding menstrual cycle, duration of luteal phase, and 
plasma immunoreactive LH and P4 concentrations but with an immature endome-
trium histologically. These clinicians were the first who assessed the progesterone 
receptors in the endometrium, as it was recognized 5 years later by Chrousos et al. 
[96]. PR is discussed together with other hormones’ resistances, and it is a clinical 
consequence of many gynecological disorders regarding the ovaries—PCOS, the 
endometrium—abnormal uterine bleeding associated with endometrial hyperpla-
sia, the eutopic endometrium in endometriosis, the decidual causes of infertility or 
recurrent pregnancy loss, or the myometrium—for miscarriage and preterm birth, 
when it is lost the uterine quiescence. The fetal endometrium remains progesterone-
resistant, except when fetal distress causes decidualization and menstruation at 
birth [80], or the “neonatal menstruation,” which is a biomarker reflecting a stage 
of endometrium development that may subsequently have an impact on the repro-
ductive life of the adolescent and the young adult.
PR is discussed as the decreased sensitivity and responsiveness of the target 
tissue to bioavailable P4 [96]. In the medical literature, PR is limited to endome-
triosis, but more and more papers do not agree to this [97]. At the first glance, the 
terms “estrogen dependence” and “progesterone resistance” appear to describe 
opposite sides of the same coin. Actually, there are emerging evidences suggest-
ing that PR in endometriosis is not just a consequence of perturbed progesterone 
signal transduction caused by chronic inflammation, but it is associated with 
epigenetic chromatin changes that determine the intrinsic responsiveness of 
endometrial cells to differentiation cues [98]. The concept of “progesterone 
resistance,” and its clinical relevance, is far from being well established and it is 
in need for redefinition [98].
3.2 Estrogen and progesterone action in eutopic and ectopic endometrium
The uterus is one of the most important organs with different cell types differ-
ently influenced by sexual steroid hormones, and the relative balance of progester-
one and estrogen steroidal activity governs the function of normal endometrium 
throughout the menstrual cycle. The growth-promoting effects of estrogen during 
the proliferative phase of the cycle are countered by progesterone antiproliferative 
actions at the postovulatory onset of the secretory phase, with decidualizing the 
endometrial stroma later in the secretory phase. The steroid hormones linked to 
specific nuclear receptors which are able to bind to the promoter of target genes and 
then regulate proliferation and/or differentiation processes, in order to prepare the 
stroma/decidua for embryo’s implantation [99].
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Endometriosis is appreciated as an ultimate hormonal disease, owing much to 
its estrogen dependency and aberrations in estrogen production and metabolism 
and progesterone resistance. Several lines of evidence have linked endometriosis 
with excessive estradiol (E2) signaling in the ectopic tissues [100]. The high ectopic 
endometrium levels of E2 are associated with its local biosynthesis through the 
presence of very well-known enzymes (17β-hydroxysteroid dehydrogenase-1 and 
aromatase) [101, 102] and with the activation of estrogen receptors and stimulation 
of mitotic activity and inflammatory response. The proliferative, pro-inflammatory, 
and antiapoptotic effects of E2 appear to be exacerbated in women with endome-
triosis; physiological E2 concentrations are able to induce an enhanced inflam-
matory response mediated by local chemokine production and to reinforce the 
mechanisms of cell survival mediated by extracellular signal-regulated kinases and 
Bcl-2 [103]. Progesterone controls endometrial proliferation and differentiation, 
which are important cellular events in uterine function—normal menstruation, 
embryo implantation, and protection against the development of estrogen-driven 
endometrial cancer. The postovulatory surge in P4 triggers a highly coordinated and 
sequential response as arrest of estrogen-dependent epithelial cell proliferation, 
followed by the secretory transformation of the glands, recruitment of various bone 
marrow-derived immune cells, and angiogenesis [104]. P4 acts on stromal cells of 
the normal endometrium and is inducing the secretion of paracrine factor(s), which 
are inducing the expression of the enzyme 17β-hydroxysteroid dehydrogenase type 
2 (17β-HSD-2) which metabolizes the biologically active estrogen E2 to estrone (E1), 
in the neighboring epithelial cells, and the epithelial cell proliferation is arrested.
Since then it is known that progesterone reduces natural killer (NK) cell activity 
[105], increases suppressor cell levels [106], inhibits cytotoxic T-cell activity [107], 
induces the production of lymphocyte-blocking proteins [108], and modifies the 
cytokine response from the Th-1 to the pre-pregnancy Th-2 pattern [109]. All these 
cytokines are involved actually in the defense to the ectopic retrograde endometrial 
debris, exosomes, and endometrial stromal stem cells.
Recently in the USA, in Michigan State University—in the Departments of 
Comparative Biosciences, of Animal Science, and of Molecular & Integrative 
Physiology, the effects of progesterone to alleviate endometriosis, induced in the 
peritoneal cavities of immunocompetent female mouse and maintained with exog-
enous estrogen, if the administration is before the induced endometriotic lesions 
are discussed (Table 1) [110].
P4 is regulating multiple events on reproductive tissues, the responses to P4 
are vastly different in normal and ill target tissues and cells, the mechanisms 
responsible for this striking contrast in progesterone’s effects in normal versus 
diseased tissues are largely unknown, and one plausible explanation being the 
specific microenvironment within target tissues—including locally secreted factors, 
expressed receptors, and paracrine and autocrine communication—determines the 
overall effect of P4.
- P4 restricts expansion of the ectopic lesions by inhibiting endometrial cell proliferation and 
neovascularization
- P4 suppresses E2-dependent inflammatory responses in the ectopic lesions
- P4 maintains ER-α-/PR-mediated signaling; their loss in the ectopic lesions leads to resistance to P4 therapy 
if the treatment is postinduction of lesion
Table 1. 
Progesterone alleviates endometriosis, induced in the peritoneal cavities of female immunocompetent mouse 
and maintained with estrogen (after Li et al. [110]).
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3.3 Estrogens’ and progesterone receptors in eutopic and ectopic  
endometrium
The ovarian hormones, estrogen and progesterone, modulate uterine events in 
a spatiotemporal manner, from the midsecretory phase, and prepare the endome-
trium to become receptive to the blastocyst signals, and decidualized stromal cells 
are seen from the late secretory phase of the menstrual cycle.
Being an estrogen-dependent illness, aberrant levels of estrogen receptors (ER-α 
and ER-β, with their genes ESR1 and ESR2) are observed in women with endome-
triosis. Both ERs play essential roles in the establishment and development of ecto-
pic lesions [111], and ample evidence indicates that ER-β is excessively expressed 
in the ectopic lesions, when compared with normal endometrium [112], being 
described a positive ratio of miRNA ESR2 to ESR1 in endometriomas in comparison 
to endometriotic implants and eutopic endometrium [113]. The studies on knockout 
mouse have shown that the attachment of ectopic endometrium, the sizes, and the 
proliferation with endometriosis progression are associated with the presence of 
ESR2 and absence of ESR1 [114].
P4 and its receptors PR-A and PR-B have an important role in endometriosis. 
The eutopic endometrium of ill women has an attenuate answer to P4; the PR 
isoform B is not expressed in their endometrium, being only the isoform PR-A, 
because progesterone-responsive genes are not deleted in eutopic endometrium of 
ill women in comparison with normal women in the early secretory phase of the 
cycle, a fact that suggests that these women have a progesterone-resistant pheno-
type [114, 115].
Recent studies have confirmed isoform PR-A predominance in endometriotic 
ill women and have shown its presence in all menstrual cycle phases [116], as it is 
similar to the condition of endometrioid endometrial cancer, with overexpression 
of PR-A isoform. Another aspect is the higher level of PR-A in ovarian endometrio-
sis comparative to peritoneal form [116].
Gargett et al. [61] are discussing the endometrial gland estrogen receptors 
[ER-α (ESR1) and ER-β (ESR2)] and their genes ESR1 and ESR2 and PR. Using 
special markers as stage-specific embryonic antigen 1 (SSEA-1 or CD15) to local-
ize the endometrial epithelial stem/progenitor cells in the basalis of endometrial 
glands of cycling women, the SSEA-1+ endometrial epithelial cells in culture had 
greater telomerase activity, and longer telomeres, and were more quiescent with 
lower proliferation rates than SSEA-1− epithelial cells and features of progenitor 
cell populations [117]. It was revealed that in polarized epithelium, SSEA-1+ cells 
expressed lower levels of ER-α (ESR1) and PR when compared with the SSEA-1− 
cells [117], suggesting a less differentiated cell phenotype and reliance on growth 
factors released from ESR1-expressing niche cells to mediate estrogen-induced 
proliferative signals. In contrast, earlier studies [118] have shown that ESR1 is 
detected in basalis glands of the normal endometrium throughout the menstrual 
cycle, whereas functionalis expression is restricted to the proliferative stage, a fact 
that suggested to the Australian researchers that human endometrial epithelial 
progenitor cells are a subset of the SSEA-1+ population that may reside in the 
functionalis abutting the basalis.
3.4 Progesterone resistance in endometriosis: mechanisms of progesterone 
resistance in endometriosis
Endometriosis is a chronic inflammatory estrogen-dependent and proges-
terone-resistant disease, because of missing or blunted progesterone-induced 
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molecular changes or inadequate response to progesterone of both the eutopic and 
ectopic endometrial cells and tissue [119, 120], facts that are present all duration 
of the menstrual cycle. Several mechanisms were described, being discussed 
whether progesterone resistance is innate, acquired, or present in eutopic and 
ectopic tissue. Many concepts try to cover the disorder, with clinical relevance; 
the mechanisms of progesterone responsiveness converge to the reduction of the 
nuclear PRs, steroid receptor coactivators, or downstream or degradation of other 
molecular effectors (TGFβ, Dickkopf-1, retinoic acid, c-myc, etc.). The lack of 
the PR-B isoform is associated with very low levels of PR-A isoform; and in the 
conditions of stromal cell defect, P4 does not induce epithelial 17β-HSD-2 expres-
sion, and this is the cause of continuing epithelial mitosis, by the failure of E2 
metabolism to E1, mainly in women with moderate/severe disease, compared with 
the normal ones [119].
The altered ratio between PR isoforms is associated with an altered complex 
network of interactions with signaling pathways, downstream effectors, tran-
scription factors, coregulators, chromatin-remodeling factors, and DNA [120]. 
Studies have shown the role of non-genomic overactive pathways of transcription 
factors as AKT pathways [with three isoforms (Akt1, Akt2, Akt3) differently 
involved in endometriosis initiation and progression and endometrial cancer] 
and MAPK pathway (only in the stromal cells) [121]. Rapid activation of AKT 
by estradiol and progestins promotes survival of endometriotic stromal cells, by 
downregulation of PRs, with proliferation and migration of endometrial stromal 
cells [122]. Experiments on xenograft mice have proven a decreased cell viability 
and increased apoptosis to cells in culture after AKT inhibitor administration 
[92, 123]. The overactive AKT pathway is associated with the inflammatory and 
hormonal nature of endometriosis [81, 123]. Overactive AKT from endometri-
otic stromal cells attenuates also decidualization through its downstream target 
FOXO1 [124].
3.5 Progesterone receptors in eutopic and ectopic endometrium
Progesterone action has been primarily ascribed to the well-characterized 
classical signaling pathway involving ligand binding, activation of nuclear proges-
terone receptors (PRs), and subsequent activation of genes containing progesterone 
response elements (PREs). Immunohistochemistry identifies during the mid to 
late luteal phase of menstrual cycle five progesterone nuclear receptors or clas-
sic PRs (PR-A, PR-B) and the truncated isoforms (PR-C, PR-M, and PR-S; the 
PR-C is generated by the initiation of translation from further downstream, not 
recognized usually), and the two types of cell surface-associated proteins [mem-
brane progesterone receptors (mPRs) and the progesterone membrane receptor 
component (PGMRC)]. PR-A and PR-B belong to a family of ligand-activated 
transcription factors and share common structural and functional elements (i.e., 
regulatory region). The P4 genomic mechanism of action is exerted through 
specific progesterone response elements (PREs) within the promoter region of 
target genes to regulate transcription of the genes. These PRs induce classic regula-
tion of gene expression while also transducing signaling cascades that originate at 
the cell membrane and ultimately activate transcription factors. As for estrogens 
the genomic and non-genomic mechanisms of P4 are coupled, and the nuclear PRs 
are upregulated by E2 in endometrial cells, implicating crucial progenitor cells, as 
preferential targets of P4.
A functional feedback interaction between the P4 and estrogen hormonal 
systems is crucial for normal endometrial differentiation/decidualization—a key 
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step toward the establishment of pregnancy, and for balancing the often-opposing 
actions of the progesterone/PR and estrogen/ER systems [125].
Recently, a new paradigm of the direct effect of P4 on the cells’ chromatin, 
with chromatin remodeling and gene regulation in stem/progenitor cells, is 
discussed. The interaction of nuclear receptors and other transcription factors 
with the chromatin is considered to be a highly dynamic process, characterized by 
rapid cycles, measured in seconds of transient association and dissociation with 
the chromatin [126]. The classic description was a static one, considering a slow 
process during hours and sometimes days and during which PRs are activated, 
then bind to the promoter of target genes, recruit coregulators, and assemble 
them in a multimeric complex that has the right enzymatic activity to modify the 
local chromatin structure, which in turn will lead to changes in the transcrip-
tional machinery, efficacy of RNA synthesis, translation, and, ultimately, protein 
levels. The “non-genomic” mechanisms explain the rapid activation of cyto-
plasmic kinase signaling that can result in both transcription-independent and 
transcription-dependent effects. These “non-genomic” actions can be partially 
explained by membrane transport via nuclear receptor. The mPRs (molecular 
mass of approximately 40 kDa) had thought to be composed of three subtypes, 
mPR-α, mPR-β, and mPR-γ, which belong to the seven-transmembrane domain 
adiponectin Q receptor (PAQR) family, plus two new discovered subtypes (mPRδ 
and mPRε). Progesterone receptor membrane component-1 (PGRMC-1) and 
PGRMC-2, with a single-transmembrane domain protein, are mediating the rapid 
non-genomic effects of E2 and P4, such as the activation of MAPK signaling and 
intracellular Ca2+ increase [127, 128]. mPRβ activates also MAPK cascade, without 
GPCR signaling, and progesterone-stimulated mPRβ activation did not exhibit the 
elevation of [Ca2+] [129]. In comparison to the mPRs, the single-transmembrane 
protein Pgrmc1 (molecular mass 25–28 kDa) and the related Pgrmc2 are a part of 
a multi-protein complex that binds to P4, to other steroids, and to pharmaceutical 
compounds [127].
Actually, the novel techniques allow genome-wide mapping of binding nuclear 
receptors to DNA and real-time monitoring of transcription. PR expression in 
uterine cells is stimulated by estrogens via ER-α, and consequently progesterone 
responsiveness is dependent on the presence of an estrogenic drive [130]; low levels 
of estrogen are required for progesterone responsiveness throughout the luteal 
phase, and, conversely, ER-α expression in uterine cells is inhibited by progesterone 
via PRs [131]. It is known that continuous exposure of the endometrium to proges-
terone downregulates PR expression in the endometrial epithelium [132], the PR 
being detected only in stroma and myometrium throughout most of gestation in the 
ovine uterus [133].
Endometrial biopsies from luteal phase (days 15 ± 31) of normal, fertile subjects 
detected a steady decrease in expression of stromal cell PRs (both isoforms A and B) 
immunostaining from a mid-cycle maximum and a more rapid decrease in expres-
sion of PR in epithelial cell, particularly between days 22 and 24, from the mid-cycle 
maximum also [134, 135].
The human nuclear PRs are encoded by a single gene located on chromosome 
11 (11q22–11q23). Expression of PR is controlled by two promoters to produce two 
major mRNA transcripts that encode two proteins: the full-length PR-B (116 kDa) 
controlled by the distal PR-B promoter region and initiated from the first AUG 
translational start codon and PR-A (94 kDa) controlled by the proximal PR-A 
promoter region and initiated from the second AUG (492 bases upstream) trans-
lational start codon. It is now generally accepted that response to P4 is determined 
by the combined actions of PR-A and PR-B, which upon ligand binding form 
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homodimers or heterodimers that have distinct transcriptional activities at 
specific sets of gene promoters.
The PR initiates paracrine signaling within the uterine microenvironment dur-
ing the preimplantation period and of extrauterine microenvironment in cases of 
ectopic endometrium. P4 facilitates the subsequent downstream expression of PR 
targets within the epithelium and stroma. The potential molecular pathways which 
are involved in the pathological mechanisms and in endometriosis were assessed 
and determined: c-Jun, CREB-binding protein, protein kinase B (AKT), and cyclin 
D1 (CCND1) signaling [136].
The dysregulation of the PR isoforms has been shown to occur in women with 
endometriosis, demonstrating the integral requirement for proper balance of these 
isoforms in hormone-responsive tissues [114].
PRs are differentially expressed in the endometrial structures—glands and 
stroma, and during menstrual cycle. The transformation of endometrial stromal 
fibroblasts (ESC) into specialized secretory cells (decidualization) is fundamental 
for the establishment of a receptive endometrial microenvironment which can sup-
port and maintain pregnancy.
PR-A is exerting a negative control on PR-B-mediated transcription and the 
mediated transcription of the ER and glucocorticoid receptors [137], a fact that 
may underlie, at least in part, the mechanism by which progesterone functionally 
antagonizes the effects of estrogen. PR-A and PR-B can interact as dimers with 
DNA progesterone-responsive element and with signaling proteins of the Src/Ras/
Erk pathway outside the nucleus [138].
De novo motif analysis indicated that, although the two isoforms bind to 
the same DNA sequence motif, they are both common and unique neighboring 
motifs where other transcription factors, such as FOSL1/FOSL2, JUN, C/EBPβ, 
and STAT3, bind to and dictate the transcriptional activities of these isoforms. 
Chromatin immunoprecipitation sequencing in combination with gene expres-
sion profiling revealed that PR-B controls a substantially larger cistrome and 
transcriptome than PR-A during human endometrial stem cell differentiation 
(Figure 4).
Figure 4. 
Progesterone action on the epithelial and stromal cells of the endometrium to prepare it for embryo receptivity. 
Progesterone has both a direct influence on endometrial epithelium via PR-B, and an indirect influence via the 
endometrial stromal cells. Adapted from Groll and Lessey [196].
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4.  Genomic and epigenetic changes of adult stem cells in ectopic and 
eutopic endometrium: heredity in endometriosis
Women suffering from endometriosis were observed since then to have pecu-
liarities including genetic predisposition, aberrant immunological response, and 
altered peritoneal environment that make them susceptible to attachment and 
growth of ectopic endometrial cells, with their exosomes, and that the ectopic 
endometriotic lesions are histologically similar to their putative eutopic precursors, 
yet significant biochemical differences exist between these two tissues. The findings 
provide a framework for causality and mechanisms underlying attenuate proges-
terone response in endometriosis, especially in the deeply infiltrating groups, but 
there are still unclear or controverted aspects in the genetics and consequences of 
progesterone resistance in endometriosis [139].
4.1 Genomic regulation in endometriosis
The genetic aspects in endometriosis must be referred to the complex patho-
genomic architecture and multiple interactions of the genetic qualities of the 
migratory and adhesive mesenchymal/stromal cells, to the qualities of the tissues/
organs where the ectopic endometrial cells arrive, and to other factors involved in 
the development of the disease, as the complex combinations of functional protein 
modules, and alteration of different metabolic pathways by sexual steroid hor-
mones, their receptors and co-regulators, and immune systems. The genes of endo-
metrial stem cells, such as OCT4, SOX2, SOX15, NOTCH1, and TWIST1, which can 
be deregulated in endometriosis, leading to altered SC behavior of migration and 
adhesivity in ectopic location, which is associated with miRNA of angiogenic factors 
[42]. The transcriptome analysis of eutopic and ectopic endometrium shows genetic 
peculiarities in women with endometriosis versus disease-free women [140–142], 
with relevant dysregulation of the proliferative-to-secretory transition in the 
endometrium in cases with endometriosis, PR gene polymorphism, and epigenetic 
alterations in stem cell populations, and their resulting exosomes in endometriosis, 
including imbalance of miRNA expression of PRs, histone and DNA modifications, 
and chromosomal aberrations, are some possible answers to the unclear pathophysi-
ologic aspects and to some clinical relevance complications—as chronic severe pel-
vic pain, dyspareunia, infertility, miscarriages, recurrent pregnancy loss, preterm 
birth, and progression to malignancy, specially of the ovary, which were assessed 
by recent, large international collaborative studies [143, 144]. There are questions 
about the relationships between eutopic and ectopic endometria, regarding the 
trigger of progesterone-attenuated response and infertility [145]. It is unknown if 
the defective endometrium gives rise to a predisposition toward endometriosis and 
infertility or, alternatively, if endometriosis causes the altered endometrial receptiv-
ity, in cases with failure of ART. In experiments on mice, the methylation of Hoxa 10 
and Hoxa 11 (known as a potential mechanism responsible for altered gene expres-
sion) decreased the endometrial receptivity in the endometriosis group.
The eutopic endometrium of ill women has an attenuate response to P4 because 
estrogen-responsive genes are nor suppressed in their stromal cells comparative to 
normal women in early secretory phase of menstrual cycle, a fact that suggests a 
resistant phenotype to progesterone [111, 114, 115].
4.2 Heredity in endometriosis
Since the 1990s, there is increasing evidence of a germline predisposition to 
endometriosis. A familial clustering of endometriosis in humans [146] and rhesus 
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monkeys [147] as well as increased prevalence among first-degree relatives of 
women with all disease severities compared to the general population [148] has 
been reported. The age at onset of symptoms is similar in affected, non-twin sisters 
[149], and there is concordance in monozygotic twins [147]. The complex gyne-
cologic disorder of endometriosis was since then recognized as showing heritable 
tendencies, with recurrent risks of 5–7% for first-degree relatives [150]. Familial and 
epidemiologic studies support that this disease is a genetic disorder of polygenic/
multifactorial inheritance, being determined the number and locations of causative 
genes. Using microarray for real-time PCR validation for the genome-wide linkage 
analysis, in a study of 1176 families with affected sibling pairs versus disease-free 
women, Treloar et al. [151] identified a region of significant linkage to endometriosis 
on chromosome 10q26, and four genes [a disintegrin and metalloproteinase domain 
12 (ADAM12; 10q26.3; 2.29 ESE), arginyltransferase 1 (ATE1; 10q26.13; 1.61 PE, 1.57 
ESE), and fibronectin type III and ankyrin repeat domains 1 (FANK1; 10q26.2; −1.85 
ESE)] which have statistical significant changes, but the gene CYP26A1 had a fold 
change in the real-time PCR analysis that did not reach statistical significance. After 
the publication of this study, there are debates on the familial aggregation [152, 153].
4.3 Progesterone receptor polymorphism
Endometriosis is considered a polygenic disorder [154] requiring alterations 
in multiple biological pathways for the establishment and proliferation of ectopic 
endometrial cells, a fact documented in a meta-analysis of European and Japanese 
cohorts [155]. The human progesterone receptor gene is located on chromosomes 
11q22–11q23 [156].
Multiple genes are expressed differentially in the eutopic endometrium of ill 
patients vs. disease-free women; and the most studied gene expression, the HOX gene, 
was proven to be altered in stromal stem cells from the ectopic endometrium [157]. 
To date, many deregulated genes have been identified in endometriotic cells with a 
wide variety of functions, including apoptosis, vascularization, cell cycle regulation, 
DNA repair, encoding detoxification enzymes, immune system regulation, and cell 
adhesion. PR polymorphism is controverted in literature [152]; some authors consider 
to have little or no relevance in endometriosis development. The multinational study 
[144] of a total of 45,923 cis-eQTLs for 417 unique genes and 2968 trans-eQTLs affect-
ing 82 unique genes showed dynamic changes in expression of individual genes along 
the cycle, which include alteration in both mean expression and transcriptional silenc-
ing. The genetic polymorphisms predispose women to endometriosis [158], a fact that 
was not sustained by the results of three meta-analyses on association of endome-
triosis and some genetic polymorphisms coding for dioxin detoxification enzymes, 
sex steroid biosynthesis, and their receptors [159–161], even though meta-analyses is 
known to have upward biases in risk estimates. A quite old review on this topic found 
“a strikingly large amount of conflicting results” and concluded that “polymorphisms 
may have a limited value in assessing possible development of endometriosis” [152].
The endometrial specimens in different phases of the menstrual cycle, mainly 
in the secretory phase, were analyzed and there was demonstrated a signature of 
enhanced cellular survival, persistent expression of genes involved in DNA syn-
thesis, and cellular mitosis in the setting of endometriosis, were analyzed, and, on 
another hand, the genes for susceptibility of attenuated progesterone response when 
in endometriosis from the families FOXO1A, MIG6, and CYP26A1 (151), HOX [142], 
WNT [68], and 12 single nucleotide polymorphisms at 10 independent genetic loci 
associated with endometriosis have also been identified were identified [162].
Comparative gene expression analysis of progesterone-regulated genes in secre-
tory-phase endometrium confirmed the observation of attenuated progesterone 
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response, which is the main issue of this chapter. The genetic polymorphism of PRs 
was studied also on PROGINS receptor gene [163], recently on the PROGINS allele 
[143], and on +331G/A genes (especially for comparison between superficial and 
deeply infiltrating endometrioses [86]). The +331C/T has been shown to influence 
the transcription of PR-B relative to PR-A with the T allele favoring PR-B [137, 164]. 
PR-B acts as a classic hormone receptor, mediating the effects of progesterone, 
whereas PR-A acts as a repressor of PR-B, and as a result, the presence of the +331T 
allele is hypothesized to lead to increase the effect of P4.
In the recent published multinational and multicenter collaborative study 
focused on the genotypes for the +331C/T SNP (associated with low risk of endo-
metriosis, because of increased synthesis of PR-B) and PROGINS allele (equivocal 
from other analyses) in cases with a history of endometriosis [144]. The occurrence 
of endometriosis was reduced in women carrying one or more copies of the +331T 
allele, whereas there was no association between the PROGINS allele and endome-
triosis (Table 2). The conclusion regarding PRs was that the +331T allele drives to 
a reduced PR-A to PR-B ratio, and if the observed association with endometriosis 
is confirmed, it would suggest that this ratio is important for endometriosis; more 
than this the authors’ conclusion was that a reduced risk is biologically plausible 
since endometriosis is responsive to progesterone.
4.4 Progesterone target genes
In the last 15–20 years, the relationship between PR-A and PR B is more and 
more understood. The exclusive expression of PR-B in the luminal epithelium may 
act as a reservoir of PR-A heterodimerizing partners, or PR-B may homodimerize 
and regulate epithelial target genes. The expression ratio of the PR isoforms within 
the uterine compartments could potentially regulate the gene expression profile; it 
was observed in ill women. The expression of progesterone target genes is blunted, 
and decidualization is inadequate [115]. The prototype progesterone-responsive 
gene, glycodelin, was discovered to be strikingly downregulated in the endome-
trium of women with endometriosis compared with disease-free women [165], 
and recently glycodelin is the third biomarker for early diagnosis of endometriosis, 
besides zinc-ɑ and brain-derived neurotrophic factor (BDNF).
Other earlier studies were considering the additional effect of environmental 
factors as dioxin to genes [166] or the interaction between multiple genes and/or the 
interaction between genes to other factors to produce the disease phenotype [167].
The location of endometrial stem cells outside the uterus may be another expla-
nation of their different actions in ectopic and eutopic endometrium in ill women in 








OR (95% CI) p-Value phet
+331 C/T 
(rs10895068)





343 5339 0.94 (0.76, 
1.16)
0.56 0.24
OR = odds ratio, compares heterozygotes and rare homozygotes to common homozygotes for +331C/T, per copy of the 
allele carried for PROGINS, stratified on study site and age group; p-value for heterogeneity across study sites.
Table 2. 
Association between the two PRs SNPs and endometriosis in the multinational study population  
(adapted from Fung et al. [144]).
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4.5 MicroRNA (miRNA) dysregulation of steroid hormone receptor expression 
in endometriosis
The receptors of sexual steroid hormones (ERs, PRs) are involved in endometri-
osis, and correlated to them is the exploration of the correlation between microRNA 
(miRNA) and ER/PR in eutopic and ectopic endometrium. There are recently 
discovered stranded noncoding RNAs (ncRNAs) [168]. MicroRNAs (miRNAs) 
are single-stranded noncoding RNA molecules with approximately 22 nucleotides 
in length, and they control posttranscriptional gene regulation, which were pro-
posed to contribute to human reproductive physiology; their abnormal expression 
was involved in the pathogenesis of many diseases of female reproductive tract, 
including endometriosis. While the majority of the literature supports the notion 
that miRNAs inhibit translation, there is some evidence that miRNAs can actually 
enhance translation in certain biological scenarios.
miRNAs are postulated to play a role in normal biological processes, to be critical 
regulators of cellular development and physiology, while their mis-expression has 
been associated with numerous diseases [169]. A recently published paper [170] 
at the Department of Molecular and Integrative Physiology, at the University of 
Kansas Medical Center (USA) tries to determine if the “mis-expressed” endometri-
otic tissue is a cause (driver of the disease) or a result of endometriosis (passenger).
More than 10 years ago, there are comparative microanalyses of genetic expres-
sions—the miRNAs in women with ectopic endometrial cells and eutopic endo-
metrium—that have proven an alternative pattern in the two groups [171–173], as 
well as the differences of ill women versus disease-free women [172–175]. miRNA 
regarding ER shows a ratio of 100:1 in ESR2 (RE-β) to ESR1 (RE-α) in endometrio-
mas vs. superficial endometriotic lesions and eutopic endometrium [112, 113].
Different miRNAs are identified by microarray with real-time reverse transcrip-
tion-polymerase chain reaction (real-time RT-PCR), and they were done in paired 
eutopic/ectopic endometrium from the same patients. In the published papers, there 
are identified upregulated (over expressed) and downregulated (underexpressed) 
miRNA expressions in eutopic and different ectopic lesion locations (peritoneal, 
ovarian), and some are “mis-expressed.” Using the Ingenuity Pathway Analysis (IPA) 
software, potential molecular pathways were assessed and determined to involve 
c-Jun, CREB-binding protein, protein kinase B (AKT), and cyclin D1 (CCND1) 
signaling, all of which have previously been associated with endometriosis patho-
genesis [136]. According to the involvement in endometriosis, the molecules directly 
involved in endometriosis (cytokines, enzymes, growth factors, kinases, ion chan-
nels, ligand-dependent nuclear receptors, peptidases, phosphatases) are assessed.
There are differences between authors; there were conflicting reports on 
whether or not miRNA expression was influenced by the stage of the menstrual 
cycle (proliferative [136] or secretory [176]), the type of endometrial cell (miRNA 
of endometrial stromal cells was for the first time assessed by Hawkins et al. [177]), 
the type of miRNA, and the level in eutopic and ectopic tissue [miRNA from miR-
29 family (was evaluated using primary human endometrial stromal cells in vitro)], 
which had different levels—(high for [136] and [176] and decreased for [178], 
who compared it to disease-free women). The role of miR-29c in endometrial cell 
proliferation, invasion, and apoptosis in vitro was examined. miR-29c suppressed 
endometrial cell proliferation and invasion, promoting cell apoptosis. The conclu-
sion was that miR-29c exhibits inhibitory action on endometrial cell proliferation 
and invasion by inhibiting the expression of c-Jun. Another studied miRNA—the 
stromal cell miR-183, was examined in response to ovarian steroids (17β-estradiol 
and P4), and inflammatory cytokines (TNF-α) were concluded from this study 
that repressed levels of miR-183 may modulate the growth and invasive potential of 
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endometriotic endometrial stromal cells contributing to the development and pro-
gression of endometriosis [179]. The microarray to identify differentially expressed 
miRNAs between endometriotic lesion tissues from women with stage III/IV 
disease compared with eutopic endometrium from women without endometriosis 
has shown that lesion tissue expressed significantly higher levels of expression of 
seven miRNAs and significantly lower levels of expression of ten miRNAs [180]; 
some miRNAs were predictors of angiogenesis in endometriotic lesions. Expression 
of VEGFA was significantly upregulated, whereas EGFR2, PTEN, and CXCR4 
were markedly downregulated in lesion tissue compared with the endometrium 
from women without endometriosis. The authors concluded that the differentially 
expressed miRNAs could modulate VEGFA, EGFR2, PTEN, and/or CXCR4 expres-
sion and contribute to the pathogenesis of endometriosis. Their conclusion is quite 
similar to other researchers from Spain [181]: the expression levels of miRNAs 
related to angiogenesis (the pro-angiogenic factors (VEGF-A) and the angiogenesis 
inhibitor thrombospondin-1 (TSP-I) are different in eutopic endometrium from 
that observed in ovarian endometrioma, rectovaginal nodule. Ovarian endome-
triomas exhibited significantly lower levels of pro-angiogenic VEGF-A mRNA and 
protein and higher levels of miR-125a and miR-222 than the corresponding eutopic 
endometrium. In contrast, levels of the angiogenesis inhibitor were significantly 
higher in endometriomas, and this was associated with reduced levels of miR-17-5p.
According to the results of the last mentioned study [170], it was considered 
that from the initial generation of miRNA profiles, investigations were focused on 
specific miRNAs and putative targets, which can become relevant to the patho-
physiology of endometriosis and may aid in determining whether these miRNAs 
function as drivers of the disease.
miR-126 was proposed to be analyzed as a regulator of angiogenesis, growth, 
adhesion, and invasion in ectopic endometriotic lesions versus eutopic endome-
trium of disease-free women, and the results of this parameter are discordant—
higher in earlier studies [136], and reduced in the more recent one, the level of 
reduction being parallel to the severity of endometrioma [182].
4.6 Epigenetics in endometriosis: methylation pattern of sexual steroid 
hormone receptors
There is accumulating evidence that various epigenetic aberrations exist in 
endometriosis. In the last 10 years, evidence from reviewed and retrieved studies 
has emerged that endometriosis may be an epigenetic disease [153], epigenetics 
appearing to have a better explanatory power than genetics, and to be a common 
denominator for hormonal and immunological aberrations in the puzzle of endo-
metriosis. Genomic imprinting; DNA methylation; histone modifications with dif-
ferent nominations (acetylation/ histone phosphorylation/histone ubiquitylation/
histone sumoylation); microRNAs [183] and recently discovered, stranded, non-
coding RNAs (ncRNAs) [168]; transcription factor network; and chromatin remod-
eling are known to regulate transcription of target genes. Genomic imprinting is an 
epigenetic phenomenon known to regulate DNA methylation of either maternal or 
paternal alleles [184], and the male and female germ lines guide the allele-specific 
DNA methylation marking and histone modification onto specific gene regions of 
parental alleles [185]. The epigenome, the collection of DNA methylation, and the 
histone modifications can be influenced by environmental factors. Exposure to 
xenobiotics, chronic inflammation, and transient hypoxia are associated with DNA 
hypomethylation of stromal endometrial stem cells through the destabilization of 
DNMT1 mRNA; DNMT1, DNMT3A, and DNMT3B are overexpressed in the epithe-
lial component of endometriotic implants as compared to normal controls or in the 
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eutopic endometrium of women with endometriosis [186], but fetal programming 
postulates that chronic adult-onset diseases with an epigenetic component originate 
in utero when the early embryo is exposed to factors that permanently shape its 
epigenetic mark, a fact presented in the previous subchapter.
Aberrant DNA methylation represents a possible mechanism, linking gene 
expression alterations observed in endometriosis with hormonal and environ-
mental factors. Methylation is one of the most important epigenetic functions that 
implies the addition of methyl group at the DNA dinucleotides in the position 5 of 
the cytosine of the “promoter” zone and induces silencing of the gene under DNA 
methyltransferase action [68, 187].
Endometriotic lesions have altered methylation patterns of ER-β, and the ER 
may mediate regulation of one another [188]. The authors consider that aberrant 
DNA hypomethylation of ER may favor the progression to cancer of old ectopic 
endometrial lesions.
DNA methylation makes possible the process “epithelial to mesenchymal transi-
tion” (EMT), in which the epithelial cells lose polarized organization of the cyto-
skeleton and cell-to-cell contacts, acquiring the high motility of mesenchymal cells. 
It is supposed that two stimulating signals, hypoxia and estrogen, can activate the 
EMT process in endometriosis through different pathways. The pathways involve 
many cellular factors such as TGF-β and Wnt, ultimately leading to cell proliferation 
and migration, and the changes of epithelial cells are thought to be prerequisites for 
the original establishment of ectopic endometriosis lesions [189].
The reasons for non-response to progestins in endometriosis are not entirely 
clear, studies point the possible epigenetic silencing of the PR gene, without knowl-
edge of causes for the epigenetic silencing of PRs. DNA methylation of the ER and 
PR promoter has been demonstrated in endometriosis; inflammation and oxidative 
stress can be involved in epigenetic changes in DNA and chromatin remodeling 
proteins [190–192]. ER-β promoter is hypomethylated in endometriotic cells, which 
accounts for its overexpression [193]. The promoter of PR-B hypermethylation 
is concomitant to reduction of PR-B, a fact explaining progesterone resistance in 
endometriosis [11, 114].
Ectopic endometrial  stromal cells are hypomethylated,  and are different from 
normal endometrial  stromal cells which are hypermethylated [194].
The hypermethylation of HOXA 10 promoter reduces HOXA 10 expression in 
induced endometriosis of stromal endometrial cells of mice [195].
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